Results 161 to 170 of about 7,479 (177)

Phenotype and Course of Hutchinson–Gilford Progeria Syndrome

New England Journal of Medicine, 2008
Vandana Sachdev, Brian P Brooks, Lynn H Gerber   +2 more
exaly  

Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome

Nature Medicine, 2019
Olaya Santiago-Fernández, Victor Quesada, Francisco Rodriguez   +2 more
exaly  

Recent progress in Lynch syndrome and other familial colorectal cancer syndromes

Ca-A Cancer Journal for Clinicians, 2018
Patrick M Boland, Matthew B Yurgelun, Clement Richard Boland   +2 more
exaly  

Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome

Circulation, 2016
Joseph M Massaro, Ara Nazarian, Mark W. Kieran   +2 more
exaly  

Defective Extracellular Pyrophosphate Metabolism Promotes Vascular Calcification in a Mouse Model of Hutchinson-Gilford Progeria Syndrome That Is Ameliorated on Pyrophosphate Treatment

Circulation, 2013
Ricardo Villa-Bellosta, José Rivera-Torres, Rebeca Acin-Perez   +2 more
exaly  

Progeria syndromes and ageing: what is the connection?

Nature Reviews Molecular Cell Biology, 2010
Brian Keith Kennedy
exaly  

Werner and Hutchinson–Gilford progeria syndromes: mechanistic basis of human progeroid diseases

Nature Reviews Molecular Cell Biology, 2007
Brian Keith Kennedy
exaly  

Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome

Circulation, 2014
Leslie B Gordon, Joseph M Massaro, Mark W. Kieran   +2 more
exaly  

Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome

Nature Medicine, 2019
Ergin Beyret, Reyna Hernandez-Benitez, Galina Erikson   +2 more
exaly  

Hutchinson–Gilford Progeria Syndrome

New England Journal of Medicine, 2008
Luigi Ferrucci
exaly